Corporate | 24 February 2006 13:18

MediClin reports preliminary figures for financial year 2005MediClin AG:

Corporate-news transmitted by DGAP – a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. —————————————————————————— MediClin AG reports preliminary figures for financial year 2005 – Sales revenues increased by 3.5 per cent – Turnaround achieved – net profit 7.7 million Euro Frankfurt, 24 February 2006 – MediClin has achieved the turnaround in it’s financial year 2005. Sales revenues increased by 12.5 million Euro or 3.5 per cent to the amount of 370.4 million Euro. More sales, tight cost management and rental relief have made a contribution to reach a preliminary operating result of 16.1 million Euro (previous year minus 12.8 million Euro). The preliminary consolidated net result improved to 7.7 million Euro after minus 15.8 million Euro in 2004. The consolidated result of the previous year was burdened with 9.1 million Euro by goodwill depreciation. Earnings per share amount to 0.24 Euro (previous year: minus 0.50 Euro). For 2006 the Board of Management assumes an moderate increase in sales and earning at previous year’s level. Cost saving and efficiency improvement measures show effect MediClin benefits to the full extent of the cost saving and target-oriented efficiency improvement measures in the financial year 2005. Cost of materials developed with 76.1 million Euro adequate to the business development despite increased energy costs. Personnel costs amounted to 209.6 million Euro and were slightly below previous year’s figure. The number of full time employees were 5,248 (previous year: 5,298) at annual average. Other operating expenses fell by 7.6 million Euro to 69.0 million Euro (previous year: 76.6 million Euro), due to a lowering in administration costs and mainly due to the less rental expenses. The cash flow of operating activities were 13.3 million Euro (previous year: 8.5 million Euro). Investments in 2005 amounted to 14.1 million Euro (previous year: 12.5 million Euro). Number of nursing days and number of cases increased The number of nursing days increased group-wide by 3.2 per cent up to 2,133,096 nursing days and the number of cases (without nursing care segment) rose by 0.7 per cent to 102,836. Development of the fourth quarter was stable Also in the fourth quarter of 2005 the positive trend of the whole year was intact, so sales amounted to 94.5 million Euro (previous year: 92.1 million Euro), at the level as in the third quarter. The final financial statements for 2005 will be published on 30 March 2006. As from that date, the Annual Report 2005 will be available at www.mediclin.de and in a printed version. Key figures – year on year comparison Group in million Euro 2005e 2004 Sales revenues 370.4 358.0 Cost of materials 76.1 73.2 Personnel expenses 209.6 209.7 Depreciation 7.1 19.0 Other operating expenses 69.0 76,6 Operating result 16.1 -12.8 Consolidated net profit/net loss 7.7 -15.8 Cashflow* 13.3 8.5 Earnings per share in Euro 0.24 -0.5 ‘Number of employees (in full time staff)’ 5,248 5,298 *from operating activities Development of the quarters 2005 – Group in million Euro Q1 Q2 Q3 Q4 Sales revenues 87.5 93.9 94.6 94.5 Operating result -1.1 3.7 7.1 6.4 Consolidated net profit/net loss -3.0 2.0 5.6 3.1 Earnings per share in Euro -0.09 0.06 0.17 0.10 About MediClin AG (Ticker: MED; WKN: 659 610) MediClin AG is a nation-wide clinic operator with head office in Frankfurt. The administrative headquarters of the clinics and health care facilities are located in Offenburg. With 30 clinics and 7 nursing care facilities and 2 Medizinische Versorgungszentren (medical care units) in 11 federal states MediClin has a total capacity of approximately 7,700 beds. MediClin’s facilities include acute care clinics, i.e., general hospitals, special treatment facilities, specialised hospitals and clinics for post-acute treatment and medical rehabilitation. MediClin has approximately 6,900 employees. Important notice: This press release includes future-oriented statements which are based on assumptions and estimates. While MediClin AG is of the opinion that these assumptions and estimates are correct, the actual future developments and actual future results may deviate from these assumptions and estimates due to the impact of various factors such as changes in the economic conditions in Germany, legal changes concerning the health system, changes relating to cost providers’ expense behaviour. MediClin does not assume liability and gives no warranty that future developments and the income actually achieved in the future will comply with the assumptions and estimates stated in this press release. (c)DGAP 24.02.2006 ————————————————————————— language: English emitter: MediClin AG Wilhelm-Leuschner-Straße 9-11 60329 Frankfurt am Main Deutschland phone: +49 (0)69 25 60 02-0 fax: +49 (0)69 25 60 02-69 email: ute.brauer@mediclin.de WWW: www.mediclin.de ISIN: DE0006595101 WKN: 659510 indexes: stockmarkets: Geregelter Markt in Frankfurt; Freiverkehr in Berlin-Bremen, Düsseldorf, Hamburg, Stuttgart End of News DGAP News-Service —————————————————————————